Delivery Order 75F40121D00007-75F40122F19002
Award Date
5/17/22
Potential Completion Date
3/30/26
Potential Value
$70K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) has awarded a $39,657.00 firm fixed-price delivery order to Pacific Biosciences of California, Inc. (PacBio) under the company's existing $1 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract with the agency. This delivery order is for the purchase of specific supplies and reagents to support the agency's use of PacBio's Sequel IIe long-read DNA/RNA sequencing platform. The award, made without a set-aside designation, is the latest task...
The U.S. Food and Drug Administration (FDA) awarded a $40,473.60 firm fixed-price purchase order to Pacific Biosciences of California, Inc. (PacBio), a small business manufacturer, to provide reagents and consumables for the agency's PacBio Revio sequencing instrument system. This order was issued under a $1 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract that PacBio holds with the FDA for sequencing reagents, kits, and consumables to support the agency's genomic...
This is a $46,512 firm-fixed price purchase order awarded by the U.S. Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer, for the delivery of reagents and consumables compatible with the FDA's PacBio Revio DNA/RNA sequencing instrument. The award is the result of a small business set-aside solicitation for these specialized sequencing supplies to support the FDA National Center for Toxicological Research's (NCTR) error-corrected...
This is a firm-fixed price purchase order awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for $24,357.60 to provide PacBio reagents. The contract has a completion date of September 30, 2024 and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are used by federal agencies like the FDA, CDC, USDA, and NIH to support genomic research across...
This is a firm fixed-price definitive contract awarded by the Department of Health and Human Services' Food and Drug Administration to Pacific Biosciences of California, Inc., a small business manufacturer of specialized scientific equipment and consumables. The contract, valued at $736,000.00, is for the provision of Pacific Biosciences' Sequel and Sequel II real-time DNA/RNA sequencing systems, along with associated reagent kits, adapters, and software to support the FDA's genomic research...
The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...
This federal contract award is for the procurement of PacBio Sequel II and IIe system reagents and consumables by the Food and Drug Administration (FDA). The $15,713.10 firm-fixed price contract was awarded on July 23, 2024 to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing platforms and associated products. The contract does not have a set-aside designation. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a manufacturer of scientific equipment and reagents, for the provision of their Sequel and Sequel II DNA/RNA sequencing systems and associated consumables. The contract has a potential value of $197,441.19 and a completion date of October 12, 2017. Pacific Biosciences has fulfilled over $10 million in federal contracts with...
This federal contract award to Pacific Biosciences of California, Inc. is a delivery order under an Indefinite Delivery Indefinite Quantity (IDIQ) contract #75F40121D00007 with the Food and Drug Administration (FDA). The purpose is to purchase specific supplies and reagents for the PacBio Sequel IIe long-read DNA/RNA sequencer. The award is for a firm fixed-price of $46,341.66, with a period of performance through May 30, 2025. Pacific Biosciences is the original equipment manufacturer for the...
This is a $504,000.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for a standard PacBio service contract with a base period plus four option years. The contract is for the provision of PART NUMBER 100-236-400 and is not set aside. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to support genomic...